Although not fully confirmed so far, PD-1/PD-L1 seems to be involved in loss of peripheral tolerance in human vitiligo, with PD-1 being expressed on regulatory and CD8+ T cells, and in vivo PD-L1 protein therapy reversing depigmentation in murine vitiligo. Here, CD274 is linked to vitiligo.